Factors That Affect the Duration of the Interval Between the Completion of Palliative Chemotherapy and Death-Reference-Cited by-同舟云学术

Factors That Affect the Duration of the Interval Between the Completion of Palliative Chemotherapy and Death

Published:2009-07-01 Issue:7 Volume:14 Page:752-759
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Hashimoto Kenji¹,Yonemori Kan¹,Katsumata Noriyuki¹,Hotchi Marika²,Kouno Tsutomu¹,Shimizu Chikako¹,Tamura Kenji¹,Ando Masashi¹,Takeuchi Masahiro²,Fujiwara Yasuhiro¹

Affiliation:

1. Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

2. Division of Biostatistics, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan

Abstract

Learning Objectives Formulate an end-of-life treatment plan for end-of-life patients who choose palliative chemotherapy. Select advanced cancer patients who are candidates for hospice care. Educate patients regarding the merits of hospice care versus palliative chemotherapy near the end-of-life stage and help them make decisions reflecting their goals. This article is available for continuing medical education credit at CME.TheOncologist.com.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2008-0257

Reference22 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Trends in the aggressiveness of cancer care near the end of life;Earle;J Clin Oncol,2004

3. A systematic review of physicians’ survival predictions in terminally ill cancer patients;Glare;BMJ,2003

4. Concealment of information in clinical practice: Is lying less stressful than telling the truth?;Panagopoulou;J Clin Oncol,2008

5. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer;Matsuyama;J Clin Oncol,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Income, Education, and Medicaid Expansion on Palliative Care in Acute Myeloid Leukemia Using the National Cancer Database;Journal of Pain and Symptom Management;2024-01

2. Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review;Current Treatment Options in Oncology;2023-07-27

3. Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database;JCO Global Oncology;2022-11

4. PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort;Journal of Translational Medicine;2021-06-24

5. Effects of molecular targeting agents and immune-checkpoint inhibitors in patients with advanced cancer who are near the end of life;Palliative and Supportive Care;2021-03-17